(PTXs) are polyether macrolides found in certain dinoflagellates, sponges and shellfish, and have been associated with diarrhetic shellfish poisoning. In addition to their in vivo toxicity, some PTXs are potently cytotoxic in human cancer cell lines. Recent studies have demonstrated that disruption of the actin cytoskeleton may be a key function of these compounds, although no clarification of their mechanism of action at a molecular level was available. We have obtained an X-ray crystal structure of PTX-2 bound to actin, which, in combination with analyses of the effect of PTX-2 on purified actin filament dynamics, provides a molecular explanation for its effects on actin. PTX-2 formed a 1:1 complex with actin and engaged a novel site between subdomains 1 and 3. Based on models of the actin filament, PTX binding would disrupt key lateral contacts between the PTX-bound actin monomer and the lower lateral actin monomer within the filament, thereby capping the barbed-end. The location of this binding position within the interior of the filament indicates that it may not be accessible once polymerization has occurred, a hypothesis supported by our observation that PTX-2 caused filament capping without inducing filament severing. This mode of action is unique, as other actin filament destabilizing toxins appear to exclusively disrupt longitudinal monomer contacts, allowing many of them to sever filaments in addition to capping them. Examination of the PTX-binding site on actin provides a rationalization for the structureactivity relationships observed in vivo and in vitro, and may provide a basis for predicting toxicity of PTX analogues.
Introduction
Pectenotoxins (PTXs) are a group of macrocyclic polyethers, 1 the first members of which were isolated from the scallop Patinopecten yessoensis.
2,3
PTXs have since been identified in a wide range of shellfish and in algae of the genus Dinophysis from around the world. 1, 4 Because many PTXs are toxic to mice by intraperitoneal injection in the standard mouse bioassay for diarrhetic shellfish toxins, 2, 3, [5] [6] [7] [8] [9] the levels of some PTXs have been regulated in shellfish. 10 Some PTXs also display potent cytotoxity in vitro, causing apoptosis and a range of other responses including effects on microtubules, stress fibres, and actin. [11] [12] [13] [14] This cytotoxicity has lead to investigation of the effects of PTXs on tumours and cancer cell lines. 15, 16 To date, 14 PTXs have been isolated and characterized (see Figure 1 (a) for selected examples). 1, 17 Their common structural features include a spiroketal group, three oxolanes, a bicyclic ketal, and a six-membered cyclic hemiketal. The main differences between these compounds involve the stereochemistry of the spiroketal group and the level of oxidation at C18, C32, C34 and C38. Pectenotoxin-2 (PTX-2) is suspected to be the precursor from which many PTXs are derived through biotransformation during metabolism in the gut of bivalves.
Recent studies have indicated that some PTXs may exert some of their in vitro effects via the actin cytoskeleton. PTX-2 is reported to inhibit actin polymerization, to form a complex with G-actin, [18] [19] [20] and PTX-6 caused depolymerization of actin in neuro-blastoma cells and damaged the F-actin network in enterocytes from rabbit intestines. 21, 22 Numerous natural cytotoxins target actin as a form of chemical defense for the host organism against predators or as a means of predation or communication. 20, 23, 24 The broad importance of the actin cytoskeleton in eukaryotic cell function likely provides the basis for its selection as a target. The ability of these cytotoxins to interfere with actin cytoskeleton dynamics has allowed them to play important roles as probe molecules for chemical biology, and more recently their potential utility in Figure 1 . Chemical structures of pectenotoxins compared to that of reidispongiolide A and the X-ray crystallographic structure PTX-2 extracted from the PTX-2-actin crystal structure. (a) The chemical scaffold of pectenotoxin is shown with eight different PTX analogues and their respective chemical modifications listed below. The overall structure has been divided into "ring" and "tail" structural components similar to other actin filament-destabilizing toxins. 29, 50 (b) The chemical structure of reidispongiolide A. (c) Stereo view of the actin-bound conformation of PTX-2 is shown surrounded by experimental electron density. The F o -F c electron density omit map was contoured at 2.5 σ. Figures 1(c) , 2, 3, 6, and 7 were prepared with Pymol. the treatment of cancer has been recognized. 20, 25, 26 For a number of these compounds, such as the reidispongiolides (Figure 1(b) ), information about their interaction with actin and their mode of filament modification at a molecular level has been obtained. This allows predictions to be made about the effects design modifications may have on the pharmacological properties of natural and synthetic analogues in the interest of clinical utility. 23 Translation of this information to PTXs is challenging because they bear little or no structural resemblance to any of the known forms of actin-binding small molecules and thus predicting the nature of their interaction with actin is difficult (Figure 1(a) ). 23 In order to understand the mechanism of action of PTXs and be able to provide a rationalization for the structure-activity relationships of different PTX isoforms we have determined the X-ray crystal structure of PTX-2 in complex with actin. The structure reveals that PTX-2 interacts with a site on actin that has not previously been observed to be the target of natural small molecules. Additionally, we have characterized the effects of PTX-2 on actin filament dynamics of purified actin filaments, which provides evidence that this toxin disrupts actin filaments by a unique mechanism. Based on these studies a molecular model for PTX-2-mediated filament destabilization has been generated that will be useful for understanding how variations in PTX structures will correlate with their bioactivity.
Results and Discussion
Overview of the PTX-2-actin complex
The structure of the Ca-ATP form of actin in complex with PTX-2 was solved by molecular replacement to a resolution of 1.7 Å. The crystallographic statistics are presented in Table 1 . The electron density for PTX-2 is unequivocal and its absolute stereochemical configuration is consistent with the previously determined assignments based on X-ray crystallographic studies of the free PTX-1 molecule, 3 and NMR studies of PTX-6 derivatives ( Figure 1(c) ). 27 Crystals of actin with PTX-2 and latrunculin B bound were also obtained, which diffracted to nearly 1.4 Å, however no differences in the overall structures of actin or PTX-2 were observed. The basis for inclusion of latrunculin B in our PTX-2-actin co-crystallization was that it improved the overall size and quality of the crystals relative to those with PTX-2 only.
Contrary to previous stoichiometric analyses indicating that PTX-2 forms a 1:4 complex with G-actin, 18 the crystallographic data reveal a 1:1 complex in the asymmetric unit (Figure 2(a) ). PTX-2-bound actin assumes the "closed" conformation 28 that is typically observed for other actin complex structures (RMS deviation b 1.0 Å). Surprisingly, though the general shape of PTX-2 contains a "ring" and "tail" moiety (Figure 1(a) ), which is common to numerous filament-destabilizing toxins (Figure 1(b) ), PTX-2 interacts with a region of actin that has not previously been observed to be a target site for filament-destabilizing small molecules. While PTX-2 binds between subdomains 1 and 3 and is near the barbed end (Figure 2(a) ), the PTXbinding site is on the opposite face of actin relative to the site occupied by the trisoxazole, reidispongiolide/sphinxolide, and aplyronine families of filament-destabilizing marine toxins (Figure 2(b) ).
The binding interface
Binding of PTX-2 to actin buries 1103.4 Å 2 of surface area where 31% of the PTX-2 molecular surface area becomes inaccessible. The ring portion of PTX-2 lies flat within a shallow groove between subdomains 1 and 3, and its interaction with actin is primarily hydrophobic in nature. The ring is centered above the side-chain of Leu110 and is cradled on either side by the side-chains of Pro112 and His173 (at the conjugated diene by Pro112 and at the 5,6-spiroketal ring system by His173) (Figure 3) . A 
where R work refers to the R factor for the data utilized in the refinement and R free refers to the R factor for 5% of the data that were excluded from the refinement.
key hydrophobic interaction is also formed between the methyl of C45 and Ile75. The ring is further held by a hydrogen bond between O6 and the main chain amide of Arg177 and a water molecule that is further coordinated by the carbonyl oxygen of Arg177 ( Figure 3(b) ). Undoubtedly, the conjugated diene components of the macrolide ring provide conformational constraints to the ring shape that help ensure presentation of these key atoms to the appropriate surface of actin.
The tail of PTX-2 curves into the outer edge of the barbed-end cleft and interacts predominantly with subdomain 1. All of the polar atoms in the tail interact with actin. Altogether the tail forms four hydrogen bonds either directly with actin residues or through actin-coordinated water molecules ( Figure  3(b) ). These interactions occur at Pro109 and Asn111. The hydrophobic effect seems to contribute to the tail's coordination, as does the fact that the sixmembered cyclic hemiketal sits in a narrow hydro- phobic hole formed by Ile136, Phe375 and the β-carbon of Asn111.
PTX-2 caps but does not sever actin filaments
It has been reported that PTX-2 sequesters monomeric actin and inhibits polymerization.
18,20 PTX-6 has been shown to induce depolymerization of F-actin in neuroblastoma cells and to damage actin filaments in enterocytes from rabbit intestines. 21, 22 Using purified actin samples, we have performed biophysical analyses to determine the effects of PTX-2 on actin filament severing and capping. Our results show that PTX-2 does not induce severing of F-actin but that it very efficiently inhibits actin polymerization by capping the fast-growing barbed-end.
At 48 μM in the presence of salts and ATP, actin forms stable filaments, which sediment during low speed centrifugation (20,000g) . After a brief incubation (30 min) of F-actin with defined molar ratios of toxin (0.5:1, 1:1, 2:1 (toxin:actin)), analysis of the pelleted material by gel electrophoresis provides a measure of the stable F-actin content remaining in each sample, and thus the filament destabilizing effect of the toxin. However, due to the short incubation time, the concentration of F-actin involved, and the buffer conditions (50 mM KCl, 2 mM MgCl 2 , 1 mM ATP, 10 mM Tris-HCl, pH 7.5), the majority of filament loss cannot be attributed to depolymerization and sequestration of actin monomers from the filament ends but must correlate with F-actin severing. Previously, we demonstrated that short incubation of F-actin with the barbed-end targeting macrolides reidispongiolide A or halichondramide dramatically reduced the amount of F-actin pelleted by centrifugation, indicating that these were potent filament severing compounds. 29 Here, we show that, in contrast to reidispongiolide A and halichondramide, PTX-2 does not display severing activity even when added at a twofold molar excess over actin ( Figure 4 ). The effect observed for PTX-2 was comparable to that of latrunculin B, which does not possess filament severing ability. 30, 31 Molecules that cap the ends of actin filaments are generally capable of binding to either the barbed or pointed end of the filament and preventing further elongation of that end. 32 For PTX-2 to possess filament capping ability, its complex with an actin monomer must be capable of interacting with other actin subunits, predictably actin dimers, trimers and/or a filament end, and inhibiting further addition of actin subunits. The filament capping ability of PTX-2 was determined by measuring the effect of limited (substoichiometric) PTX-2-G-actin complexes on polymerization of a tenfold larger pool of uncomplexed G-actin using a kinetic pyrenyl fluorescence assay. 29, 33 By pre-assembling the complexes with an equimolar ratio of monomeric actin to toxin at least 12 h prior to initiation of the experiment, and adding 1 μM of the complex to 9 μM uncomplexed monomeric actin, toxin-actin complexes that are capable of filament capping would substantially reduce the rate of polymerization and thus the intensity of the pyrene fluorescence signal relative to an actin sample with no toxin-actin complex added. Alternatively, if the functionality of the toxin is limited to actin monomer sequestration, the rate of polymerization (pyrene fluorescence signal) would not be significantly different from the sample lacking the toxin-actin complex because these complexes would not contribute to, or hinder, polymerization of the uncomplexed actin monomers due to their inability to bind other actin subunits. The plot of the pyrene fluorescence signal for the PTX-2-actin complex sample over time shows that these complexes significantly inhibit filament elongation, much more so than can be attributed to monomer sequestration alone ( Figure 5(a) ). In fact, the capping activity of the PTX-2-actin complex was more robust than that observed for the filament severing toxins reidispongiolide A and halichondramide, which also displayed capping activity in previous studies. 29 To determine whether filament capping by PTX-2-actin complexes was occurring at the pointed-end or the barbed-end, the polymerization assay was also performed in the presence of gelsolin-actin seeds, which cap the barbed-end and permit filament growth from the pointed-end only. 34 Under these conditions, we observed that the PTX-2-actin seeds had less of an inhibitory effect on polymerization than observed in the absence of gelsolin-actin seeds ( Figure 5(b) ). This indicates that the PTX-2-actin complex is competing with the gelsolin seeds for the barbed-end during polymerization.
Although some filament capping molecules can inhibit depolymerization of the capped end, 32 an analysis of the ability of the PTX-2-actin cap to interfere with depolymerization from the barbedend was not conducted for the following reasons. First, reliable measurements of filament depolymerization specifically from the filament ends are difficult to obtain because the standard assays for measuring filament depolymerization do not differentiate between actin subunit disassembly from the filament ends, filament shearing that often occurs during reaction mixing, or quenching of the pyrene signal upon toxin binding. 35 Second, because the PTX-2-actin complex essentially functions as a capping protein, the interactions of this complex with the barbed-end are formally equivalent to that of G-actin alone. This presents a problem in that to perform a depolymerization experiment an excess of toxin must be added over the concentration of barbed ends. Necessarily this will result in sequestration of the actin as it is released from the pointed end. In turn this will reduce the level of "free actin" in solution, which will enhance depolymerization. As a net result, the effect of capping of the barbed end will be obscured.
Model of barbed-end capping by pectenotoxins
F-actin consists of a two-start helix in which the long-pitch strands are axially staggered by approximately half the axial subunit spacing and exhibit a right-handed helical twist. 36 Models of the F-actin structure based on electron microscopy, fiberdiffraction and observed crystallographic interactions indicate that each subunit in the filament engages in both longitudinal and lateral contacts with other subunits. [37] [38] [39] The surfaces involved in such interactions have been examined extensively by structural modeling, mutagenesis, cross-linking, proteolytic footprinting and deuterium-exchange studies, and the findings from these studies are generally in agreement with Holmes' model of F-actin architecture. 37, 40 A superposition of the PTX-2-actin complex onto this model creates a spatial overlap between PTX-2 and residues Lys191, Thr194, Glu195, Arg196, Gly197, and Ser199 in helix H8 of subdomain 4 from the lower lateral actin subunit, but does not generate a steric clash between longitudinal subunits ( Figure 6 ). Interestingly, the interaction between helix H8 and the binding surface of PTX-2 on the upper lateral monomer has not been heavily investigated as a contributor to filament stability. With the exception of a proteolytic fragment binding study, 41 few studies have suggested that helix H8 plays a critical role in lateral interactions. Instead, the H-loop has typically been credited with this role.
In addition to producing a steric clash with part of subdomain 4 from the lower lateral actin subunit in the F-actin model, PTX-2 interacts with residues between subdomains 1 and 3 (Ile75, Pro110, Pro112, Arg177, and Phe375) on G-actin that show protection upon actin polymerization in hydrogen/ deuterium exchange mass spectrometry and radiolytic footprinting experiments. 42, 43 This indicates that the PTX-2-binding surface on actin may not be accessible in F-actin, but can only be engaged in the G-actin form or at a free barbed-end. This is consistent with the observed effects of PTX-2 on purified samples of G and F-actin where PTX-2 demonstrated robust barbed-end capping ability during G-actin polymerization but was unable to sever pre-assembled actin filaments. It also indicates that PTX-2 binding at the "inner" filament axis side inhibits a lateral actin subunit interaction critical for filament assembly, thereby capping the barbed-end. Such a mechanism of filament dynamics modulation is novel to barbed-end-targeting natural products.
Structure-activity relationship of pectenotoxins
Metabolism of PTX-2 to other PTX derivatives by shellfish, and biosynthesis of analogues in algae, has provided a growing library of compounds [1] [2] [3] [4] 8, 9, 12, 17 whose cytotoxicity continues to be evaluated for potential therapeutic utility. 15 At a molecular level, this library of chemical modifications can help probe the versatility of the PTX-binding surface on actin, providing vital information toward the design of novel analogues with improved pharmacological profiles. Though no structural information on the interaction of other PTX isoforms with actin is currently available, nor are comparisons of the effect of different PTXs on purified actin filament dynamics, the structure of the PTX-2-actin complex provides an excellent model to help rationalize previous observations of the activity of different PTX isoforms in cell and mouse model systems (Figure 7) . PTX-2 is one of the most toxic PTXs in mice. 27, 44 Examination of the binding interactions of PTX-2 with actin suggests that addition of a hydroxyl group to the methyl side-chain at C34 as seen in PTX-11 probably would not have a major impact on binding to actin ( Figure 7 ). Likewise oxidation of the 18-methyl group to a hydroxymethyl, aldehyde, or carboxylate moiety as seen in PTX-1, PTX-3, and PTX-6, respectively, would not be expected to have a major effect on binding. This prediction is consistent with the recent observation that, like PTX-2, Figure 5 . Actin filament-capping activity of PTX-2. (a) The graph shows the change in pyrene fluorescence signal that occurs during polymerization of 9.0 μM G-actin (15% pyrenyl-G-actin) in the presence of 1 μM toxin-G-actin complexes as a function of time. A baseline signal was obtained for each actin sample before removal of the cuvette (at 50 s) from the fluorimeter and addition of 1 μM toxin-G-actin complex and KCl and MgCl 2 . Polymerization reaction profiles are labeled according to the toxinactin complexes added (black, 9.0 μM G-actin without toxin-actin complex; blue, halichondramide; red, PTX-2; orange, reidispongiolide A). (b) 9.0 μM G-actin was preincubated with pre-assembled gelsolin-actin seeds added at a 1:50 gelsolin:actin ratio for 5 min prior to the addition of toxin-actin complexes and salts. Control samples of 9.0 μM G-actin only and G-actin plus gelsolin seeds are shown in black and purple, respectively. Polymerization of G-actin in the presence of 1 μM PTX-2-G-actin complex only is shown in red, while the same reaction containing gelsolin seeds is shown in green.
PTX-1 and PTX-11 influence actin assembly in cellular assays. 45 Conversely, isomerisations around C7 (PTX-4, -7, -8, and -9) would be expected to change the conformation of the macrocyclic ring in ways that might be inconsistent with the interactions with His173 and Leu110, which provide critical hydrophobic interactions. Certainly, any changes in the chirality of the ring systems that make up the macrolactone ring might be expected to influence the interaction of the PTX with the shallow binding site provided by actin. In the same vein, the presence of a cis-1,2-dihydroxy system in the "tail" of 36R-PTX-12 suggests that it may bind more poorly than the trans-1,2-dihydroxy-containing 36S-PTX-12. Finally, it is likely that opening of the macrocyclic ring to form PTX seco acids would seriously interfere with binding to actin. As with all cyclic macrolides that bind to actin, the presence of a ring will reduce the conformational freedom of the unbound toxin, which will decrease the entropic cost of binding a complex molecule to a comparatively shallow hydrophobic surface. 29 Indeed, recent cellular studies have shown that the PTX-2 seco acid does not cause actin disassembly or changes in the cytoskeleton, 45 and PTX-2 seco acids are not measurably toxic in vitro 12 or in vivo. 8, 46 Further studies to measure the binding affinity of different PTX isoforms to actin, as well as clarification of the nature of the interaction other PTXs make with the actin cytoskeleton, are under way.
Conclusions
The co-crystal structure of PTX-2-actin reveals the molecular details of the actin-toxin interface. This provides key information about its chemical structure determinants for actin binding, as well as sites on PTX that can be modified during analogue synthesis or used as conjugation points for addition of targeting probes. Furthermore, the structure has allowed us to perform a cursory modeling exercise Figure 6 . Superposition of PTX-2 onto the F-actin model. The G-actin-bound conformation of PTX-2 (yellow spheres) is superimposed on the model of F-actin to illustrate the mechanism by which it caps the barbed-end of the filament. 37, 40 Four actin subunits are shown (two for each strand) in surface representation. The pointed and barbed-ends of this "minifilament" are labeled. Actin subdomains 1-4 are also labeled for each subunit and are colored as in Figure 2 . The binding position of PTX-2 is at the interior of the filament. The boxed region shows a magnification of the steric clash between PTX-2 and helix H8 from subdomain 4 of the lower lateral actin subunit (shown in cartoon representation).
to reconcile previous SAR data of PTX congeners. More in-depth structural and functional analyses of these congeners will be conducted once sufficient amounts of these toxins are available. Finally, the binding position and in vitro activity of PTX-2 suggests a new mechanism for actin filament destabilization, provides important information about F-actin subunit contacts, and underlines the abundance of sites on actin that are vulnerable to attack by natural small molecules.
Materials and Methods

Protein preparation
Actin used in crystallizations and the low speed centrifugation assay was obtained from rabbit muscle acetone powder as described. 29 For the actin filament capping assays pyrene-labeled rabbit skeletal G-actin (cat. no. AP05) and unlabeled rabbit skeletal G-actin (cat. no. AKL99) were purchased from Cytoskeleton Inc. (Denver, CO).
Toxin isolation
PTX-2 was isolated from a bloom of Dinophysis acuta harvested at Sognefjord, Norway. 8 Latrunculin B was purchased from Sigma. Reidispongiolide A was provided as a generous gift by Professor Valeria D'Auria, Università degli Studi di Napoli "Federico II", Naples, Italy. It was isolated from the sponge Reidispongia coerulea collected in the South of New Caledonia and extracted according to previously published protocols. 47, 48 Halichondramide was provided as a generous gift by Professor Junichi Tanaka, University of Ryukyus. It was collected from an unidentified black sponge collected off Iriomote Island in Okinawa and purified as described. 49, 50 The identity of all toxins was confirmed by NMR and mass spectrometry. All toxins were solubilized in 100% methanol and stored at −20°C prior to use.
Crystallization
Pectenotoxin-2 was mixed at a 1.3-fold molar excess with G-actin and then concentrated to approximately 10 mg/ml by ultrafiltration. Crystals of actin-PTX-2 were grown by hanging-drop vapor diffusion in which 5 μl of the complex was mixed with an equal volume of precipitant solution. The precipitant for the PTX-2 complex contained 100 mM Na/Mes/acetate (pH 5.5), 15% (w/v) methyl ether poly(ethylene glycol) 5000, 10% hexanediol, 30 mM CaCl 2 , and 1 mM TCEP. The actin-PTX-2-latrunculin B complex was formed by adding latrunculin B at a 1:1 molar ratio to the actin-PTX-2 complex. The precipitant for this complex contained 100 mM Na/Mes/ acetate (pH 5.5), 15% methyl ether poly(ethylene glycol) 5000, 10% hexanediol, 100 mM CaCl 2 , and 1 mM TCEP. All hanging drops were streak-seeded with crystals obtained from an initial screen 24 h after set-up. Crystals of PTX-2-actin complex grew as rectangular boxes to maximum dimensions of ∼0.4 mm × 0.05 mm × 0.05 mm in four to five days at 20°C. Crystals of PTX-2-LatB-actin complex grew as skewed tetragonal prisms to maximum dimensions of ∼0.3 mm × 0.1 mm × 0.05 mm in two weeks at 20°C. The crystals were cryopreserved by step-wise equilibration into 25%, 75%, and finally 100% cryoprotectant solution containing 100 mM Na/Mes/acetate (pH 5.5), 18% methyl ether poly(ethylene glycol) 5000, 175 mM CaCl 2 , 12% hexanediol, 10% ethylene glycol and flash frozen in a stream of nitrogen gas.
Data collection and structure refinement
Data were collected at the SBC 19-BM beam line, Advanced Photon Source in Argonne, IL. Diffraction data were integrated and scaled with the program HKL2000. 51 The structures of both complexes were solved by molecular replacement with Molrep 52 starting from the actinsphinxolide B structure (PDB accession code 2ASO 29 ). The structures were refined with Refmac and Coot. 53, 54 Structure analysis and Figure preparation Structure alignments were performed with Superpose and Align. 55, 56 Ligand-protein contacts were determined using the LPC suite and the program LIGPLOT v.4.4.2.
57,58
The total molecular surface area buried at the complex interface was determined with CNS version 1.1. 59 Figures showing toxin and actin crystal structure models were prepared with Pymol. 60 
Actin filament capping assays
Measurements of actin filament capping with actintoxin complexes were performed with pyrenyl-G-actin (cat. no. AP05) from Cytoskeleton Inc. (Denver, CO, USA). Briefly, 9.0 μM of 15% pyrenyl-G-actin in G-buffer (5 mM Tris-HCl (pH 8.0), 0.2 mM CaCl 2 , 0.2 mM ATP) in the presence or absence of 1 μM unlabeled G-actin-toxin complex (assembled by mixing an equal molar ratio of G-actin and toxin at least 12 h prior to the experiment) was mixed with 0.1 vol. of Actin Polymerization Buffer (500 mM KCl, 20 mM MgCl 2 , 10 mM ATP (cat. no. BSA02-010)) in a 200 μl cuvette. After 5 s of mixing by pipetting, fluorescence intensity of the pyrenyl actin was measured continuously for 500 s. The difference in pyrene fluorescence during polymerization was monitored at 22°C using a QuantaMaster C-60/2000 fluorimeter (Photon Technologies Inc.) with excitation and emission wavelengths of 365 and 407 nm, respectively. Slit widths were set to 1 nm. Gelsolin-actin seeds were assembled by mixing unlabeled G-actin with full-length gelsolin at a 2:1 molar ratio in G-buffer and incubating for 3 h at 22°C followed by 12 h at 4°C. For the capping assays measuring polymerization of pyrenyl-G-actin from the pointed-end, gelsolin-actin seeds were added to 9.0 μM of 15% pyrenyl-G-actin at a final concentration of 0.18 μM 5 min prior to the addition of 1 μM of actin-toxin complexes and 0.1 vol. of Actin Polymerization Buffer. 61 Graphs were refined with Kaleidagraph (version 3.6.4, Synergy Software, Reading, Pennsylvania, United States).
Actin filament severing assay
Measurements of F-actin severing were performed with rabbit skeletal muscle G-actin polymerized in 50 mM KCl, 2 mM MgCl 2 , 1 mM ATP, 10 mM Tris-HCl (pH 7.5), overnight. Toxins were added at 24 μM, 48 μM, and 96 μM (final concentrations) to 100 μl of 48 μM F-actin giving molar ratios of toxin:F-actin of 0.5:1, 1:1, and 2:1, respectively. The samples were incubated for 30 min at 4°C and then centrifuged at 20,000g for 30 min. The supernatant fraction was removed and the pellets were resuspended in 100 μl of G-buffer and analyzed by SDS-PAGE. Pellets of 48 μM G-actin without toxin added were included as controls to measure the amount of non-filamentous actin retained on the tube wall after centrifugation.
Protein Data Bank accession codes
The atomic coordinates and structure factors have been deposited in the RCSB Protein Data Bank and are available under accession codes 2Q0R (PTX-2-actin) and 2Q0U (LatB-PTX-2-actin).
